跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
慷彼申 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Oryz-Aspergillus Enzyme And Pancreatin Tablet
Approved
化学药品
Oryz-Aspergillus Enzyme And Pancreatin Tablet
Bridging Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jun 21, 2021
Approval ID
8BYsLmhu3lP
Company
Bridging Pharma GmbH
Type
化学药品
Approval Details
Approval Id
8BYsLmhu3lP
Approval Number
国药准字HJ20191029
Generic Name
米曲菌胰酶片
Generic Name En
Oryz-Aspergillus Enzyme And Pancreatin Tablet
Trade Name
慷彼申
Brand Name
慷彼申
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含米曲菌酶提取物24mg，胰酶220mg
Reg Date
2021-06-21
Expired Date
2026-06-20
Company Name
Bridging Pharma GmbH
Company Detail Path
/organization/bridging-pharma-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 21, 2021
Approval ID
8BYsLmhu3lP
Type
化学药品
Back to NMPA Approvals
